Basel Medical Group Ltd Ordinary Shares
BMGL | NASDAQ
$5.06
+$0.02 (+0.40%)
Nov 2, 2026, 3:17 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2025 Dec 31, 2025 | Q4 2024 Jun 30, 2025 |
|---|---|---|
Net Income | 268.44K | -9.94M |
Depreciation & Amortization | 2.05M | 799.14K |
Stock-Based Compensation | n/a | n/a |
Other Working Capital | n/a | n/a |
Other Non-Cash Items | 45.33K | 10.18M |
Deferred Income Tax | n/a | n/a |
Change in Working Capital | -3.99M | -1.34M |
Operating Cash Flow | -1.63M | -302.73K |
Capital Expenditures | -124.51K | -518.8K |
Cash Acquisitions | 349.39K | -9.96M |
Purchase of Investments | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a |
Other Investing Acitivies | n/a | n/a |
Investing Cash Flow | 224.88K | -10.48M |
Debt Repayment | 594.99K | -3.06M |
Common Stock Repurchased | n/a | n/a |
Dividend Paid | n/a | n/a |
Other Financial Acitivies | -1.31M | 649.21K |
Financial Cash Flow | -715.26K | 6.98M |
Net Cash Flow | -1.73M | -3.91M |
Free Cash Flow | -1.75M | -821.53K |
Adj. Free Cash Flow | -1.75M | -821.53K |
Maintenance CapEx | -124.51K | -518.8K |
Growth CapEx | n/a | n/a |
Owner Earnings | -1.75M | -821.53K |
Add to Watchlist
Select watchlists to add or remove BMGL